Intraperitoneal Chemotherapy after Interval Debulking Surgery for Advanced-Stage Ovarian Cancer: Feasibility and Outcomes at a Comprehensive Cancer Center

OBJECTIVES: Intraperitoneal (IP)-based chemotherapy following primary debulking surgery (PDS), although associated with substantial toxicity, is supported by a strong evidence base. We sought to determine feasibility and outcomes of IP chemotherapy after interval debulking surgery (IDS) among patien...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gynecol Oncol
Asıl Yazarlar: Mueller, Jennifer J., Kelly, Amelia, Zhou, Qin, Iasonos, Alexia, Roche, Kara Long, Sonoda, Yukio, O’Cearbhaill, Roisin E., Zivanovic, Oliver, Chi, Dennis S., Gardner, Ginger J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5624326/
https://ncbi.nlm.nih.gov/pubmed/27692668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.09.014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller